KAM
ASMB icon

Krensavage Asset Management’s Assembly Biosciences ASMB Stock Holding History

Krensavage Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-832
Closed -$21K – 15
2022
Q2 		$21K Sell
832
-10
-1% -$230 0.01% 14
2022
Q1 		$21K Buy
+842
New +$18.1K 0.01% 13

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Krensavage Asset Management's ASMB Position: Q3 2022 in Review

Krensavage Asset Management sold out of Assembly Biosciences (ASMB) in Q3 2022, closing a stake of 832 shares — an estimated $21K sold.

Krensavage Asset Management first reported a position in ASMB in Q1 2022 and held it in 2 quarters. The position peaked at $21K in Q2 2022. 50 funds tracked by Wall St. Rank hold ASMB as of Q3 2022.

  • Krensavage Asset Management reported no remaining Assembly Biosciences position as of Q3 2022 after selling out during the quarter.
  • Krensavage Asset Management sold 832 Assembly Biosciences shares in Q3 2022, an estimated $21K.
  • Krensavage Asset Management first reported a position in Assembly Biosciences in Q1 2022 and held it in 2 quarters.
  • Krensavage Asset Management's Assembly Biosciences position peaked at $21K in Q2 2022.
  • 50 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2022.

Based on Krensavage Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.